tDCS + Cognitive Training for Fetal Alcohol Spectrum Disorders
Trial Summary
What is the purpose of this trial?
This is a randomized placebo-controlled trial of cognitive training with transcranial direct current stimulation (tDCS) for children and adolescents (ages 8 - 17 years) with prenatal alcohol exposure (PAE).
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of this treatment for Fetal Alcohol Spectrum Disorders?
Research shows that combining transcranial direct current stimulation (tDCS) with cognitive training can improve brain function and outcomes in conditions with brain development issues, like Fetal Alcohol Spectrum Disorders. Studies in alcohol dependence have shown that tDCS can enhance brain activity and reduce cravings, suggesting it might help improve cognitive functions in FASD as well.12345
Is transcranial direct current stimulation (tDCS) safe for use in humans?
How is the tDCS + Cognitive Training treatment different from other treatments for Fetal Alcohol Spectrum Disorders?
This treatment is unique because it combines transcranial direct current stimulation (tDCS), a noninvasive brain stimulation technique that enhances brain plasticity, with cognitive training exercises. This combination aims to improve brain function more effectively than cognitive training alone, which is the most commonly studied treatment for executive deficits in Fetal Alcohol Spectrum Disorders.1891011
Research Team
Jeffrey R Wozniak, Ph.D.
Principal Investigator
University of Minnesota
Eligibility Criteria
This trial is for children and teens aged 8-17 with Fetal Alcohol Spectrum Disorders (FASD) due to heavy prenatal alcohol exposure. They need a parent or guardian to consent. It's not for those with substance abuse, other developmental disorders, serious psychiatric conditions affecting the brain, very low birthweight, or who can't have MRI or tDCS.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline visit with cognitive testing
Treatment
5 sessions of cognitive training with tDCS (active or sham)
Follow-up
Participants are monitored for changes in cognitive performance
Treatment Details
Interventions
- Active tDCS
- Cognitive Training
- Sham tDCS
Active tDCS is already approved in United Kingdom, Brazil for the following indications:
- Depression
- Depression
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor